Davis's Drug Guide
sirolimus (protein bound)
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
sir-oh-li-mus
Trade Name(s)
- Fyarro
Ther. Class.
Pharm. Class.
temporary class
mechanistic target of rapamycin (mTOR) kinase inhibitorThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Sirolimus (protein Bound)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580083/all/sirolimus__protein_bound_.
Vallerand AHA, Sanoski CAC, . Sirolimus (protein bound). Davis's Drug Guide. F.A. Davis Company; 2025. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580083/all/sirolimus__protein_bound_. Accessed April 20, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Sirolimus (protein bound). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580083/all/sirolimus__protein_bound_
Vallerand AHA, Sanoski CAC, . Sirolimus (protein Bound) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 20]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580083/all/sirolimus__protein_bound_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - sirolimus (protein bound)
ID - 3580083
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580083/all/sirolimus__protein_bound_
PB - F.A. Davis Company
ET - 19
DB - Emergency Central
DP - Unbound Medicine
ER -
